Author: Pablo Bolaños
I’m There: Series introduction
In this series we will pull back the curtain to reveal the individuals who make up the very fabric of our organization.
Treatment for heroin addiction is at an all-time high
With heroin use on the rise, it’s little wonder that more people are seeking treatment for heroin addiction than ever before.
Oregon’s Measure 91 legalizes marijuana
Oregon joins Washington, Colorado, Alaska and D.C. as the only U.S. jurisdictions where the recreational use and sale of marijuana is allowed.
Day against drug abuse and illicit trafficking
June 26 marks the annual International Day against Drug Abuse and Illicit Trafficking established by the United Nations Office of Drugs and Crime.
Customer support improvements
Our new Interactive Voice Response system will provide newly updated options for all inbound calls into our 1-800-877-7484 customer support line.
Synthetic marijuana: Catch me if you can
Difficult to detect and harmful if consumed, designer drugs are infiltrating society, leaving unequivocal damage in their wake.
Why does employee drug use matter?
Director of Science and Technology, Dr. Barry Sample highlights current drug use trends and how they affect the workplace.
Lenexa, Kansas – Quest Diagnostics’ rising star
Quest Diagnostics CEO Steve Rusckowski views the Lenexa, KS area as an ideal hub for some of Quest’s fastest up-and-coming businesses.
One of Fortune magazine’s most admired companies
With high marks for Innovation and global competitiveness, Quest stands out as the only diagnostic information services company to make the list.
More synthetic cannabinoids elevated to Schedule I ban
The Drug and Alcohol Testing Administration details the addition of three synthetic cannabinoids to the Schedule I category by the DEA.
